Neurology® Podcast

1) Guillain-Barré syndrome vs. CIDP and 2) progressive myoclonic encephalopathies. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Erik Ensrud interviews Dr. Pieter van Doorn about his paper on Guillain-Barré syndrome. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about Harlequin syndrome. In the next part of the podcast Dr. Alberto Espay interviews Dr. Berge Minassian for part 1 on progressive myoclonic encephalopathies for our Lesson of the Week. The participants had nothing to disclose except Drs. van Doorn and Espay.Dr. van Doorn receives research support from the Prinses Beatrix Fonds, the GBS-CIDP Foundation International and from Baxter biopharmaceutics.Dr. Espay received has personal compensation as a consultant for Boehringer Ingelheim; grant support from Codman; Medtronic, Inc; Allergan, Inc.; and CleveMed, and honoraria from UCB-SCHWARZ PHARMA AG; Medtronic, Inc. and Novartis.

Frontotemporal dementia and advocacy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interviews Dr. Eneida Mioshi about her paper on frontotemporal dementia. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about atypical unilateral severe facial pain in smokers. In the next part of the podcast Dr. Ted Burns interviews Dr. Robert Griggs on advocacy for our Lesson of the Week. The participants had nothing to disclose except Drs. Mioshi, Burns and Griggs.Dr. Mioshi serves on the editorial board of Dementia and Geriatric Cognitive DisordersDr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).Dr. Griggs serves on the editorial advisory board for Current Treatment Options in Neurology and NeuroRX; has received honoraria for lectures or educational activities not funded by industry; receives research support from the NINDS T32 NS07338 [PI]; NIH 2U54 NS059065-06 [PI], R01 NS045686-05 [PI], NIH-R13 Fostering Pharma, NINDS 525326 FOR-DMD, and FDA 2-RO1FD003454-02 [Co-PI] and TaroPharma; receives funding support from MDA Fostering Pharma-Academic Partnerships in Neuromuscular Experimental Therapeutics, Muscular Dystrophy Association Experimental Therapeutics of Neuromuscular Disease and Recruitment for HYP HOP Phase III trial in the Periodic paralyses (PI); and receives royalties from the publication of the book, Cecil Textbook of Medicine, 23 Edition.

Hippocampal removal and evidence-based medicine (part 1). This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ryan Overman interviews Dr. Marla Hamberger about her paper on hippocampal removal. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about the "slurp" test for children with myasthenia gravis. In the next part of the podcast Dr. Michael Benatar interviews Dr. Mark Conaway for part one on evidence-based medicine risk and rate for our Lesson of the Week. The participants had nothing to disclose except Drs. Overman and Hamberger. Dr. Overman serves as Deputy Editor on the Neurology® Resident and Fellow Section editorial team and the Neurology® Podcast Committee. Dr. Hamberger serves on the editorial board of Epilepsy and Behavior and receives research support from the NIH (NINDS R01 NS35140 [PI]). Dr. Overman serves as Deputy Editor on the Neurology® Resident and Fellow Section editorial team and the Neurology® Podcast Committee.Dr. Hamberger serves on the editorial board of Epilepsy and Behavior and receives research support from the NIH (NINDS R01 NS35140 [PI]).

Leptomeningeal metastases and acute dizziness. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Mauermann interviews Dr. Lisa DeAngelis about her paper on leptomeningeal metastases. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about hemiballism. In the next part of the podcast Dr. Beau Bruce interviews Dr. David Newman-Toker on acute dizziness for our Lesson of the Week. The participants had nothing to disclose except Dr. DeAngelis.Dr. DeAngelis has served on a scientific advisory board for Genentech, Inc.; serves on the editorial board of Neurology; receives royalties from the publication of The Neurologic Complications of Cancer (Oxford University Press, 2008); and has received research support from the NIH (UO1 CA-105663-01 [Participating Member in the NABTC]).

Safety of t-PA in stroke and Rett syndrome. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Sean Savitz about his paper on safety of t-PA in stroke. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about ophthalmoplegia in herpes zoster ophthalmicus. In the next part of the podcast Dr. Alberto Espay interviews Dr. SakkuBai Naidu for our Lesson of the Week about Rett syndrome. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Savitz and Espay. Dr. Savitz serves on a scientific advisory board for Grupo Ferrer Internacional S.A.; has received travel expenses and/or honoraria for lectures or educational activities not funded by industry; serves as an Associate Editor of Experimental and Translational Stroke Medicine; has received honoraria from Johnson & Johnson; receives research support from Athersys, the NIH R21NS064316 [PI] and R21 HD060978 [PI], the American Heart Association, and from the Howard Hughes Medical Institute.Dr. Espay received has personal compensation as a consultant for Boehringer Ingelheim; grant support from Codman; Medtronic, Inc; Allergan, Inc.; and CleveMed, and honoraria from UCB-SCHWARZ PHARMA AG; Medtronic, Inc. and Novartis.

Driving risk in dementia and survey results on sedation for imminently dying. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Russ Swerdlow interviews Dr. Don Iverson about the AAN guidelines update on driving risk in dementia. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about motor movements in brain death. In the next part of the podcast Dr. Ted Burns interviews Dr. Jim Russell for our Lesson of the Week about the AAN Ethics Section survey results on sedation for the imminently dying. The participants had nothing to disclose except Drs. Burns and Russell.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).Dr. Russell serves on the scientific advisory board for the Massachusetts Chapter of the ALS Association; and receives royalties from the publication of Neuromuscular Disorders (McGraw-Hill, 2007).

Migraine care and principles of bioethics (part 3). This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jim Gordon interviews Dr. Rachel Nardin about her paper on migraine care in the United States. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about stroke with primary brain tumors. In the next part of the podcast, Dr. Ted Burns interviews Dr Dan Larriviere for our Lesson of the week about principles of bioethics: respect of nonmaleficence. The participants had nothing to disclose except Drs. Gordon, Nardin, Burns and Larriviere.Dr. Gordon has received speaker fees from the University of Washington School of Nursing for two talks.Dr. Nardin has received honoraria for lectures not funded by industry; serves on the editorial board of Muscle & Nerve; and has received royalties from publications in Up-to-date.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).Dr. Larriviere has received honoraria for serving on the American Association for the Advancement of Science Faculty and has received an unrestricted educational grant from Allergan, Inc.

Poliovirus-infected macrophages in thymus and part two on evidence-based medicine. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Renato Bernasconi about his paper on myasthenia gravis. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about a mimic of hemicranias continua. In the next part of the podcast Dr. Michael Benatar interviews Dr. Gary Gronseth for part two on evidence-based medicine for our Lesson of the Week. The participants had nothing to disclose except Drs. Burns and Gronseth.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).Dr. Gronseth serves as an editorial advisory board member of Neurology Now; serves on a speakers bureau for Boehringer Ingelheim; and receives honoraria from Boehringer Ingelheim and the American Academy of Neurology.

Subdiaphragmatic visceral infarction and part one on evidence-based medicine. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Justin Sattin interviews Dr. Pierre Amarenco about his paper on visceral infarction in cardioembolic stroke. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about neuroimaging in paroxysmal hemicranias and SSUNCT syndrome. In the next part of the podcast Dr. Michael Benatar interviews Dr. Gary Gronseth for part one on evidence-based medicine for our Lesson of the Week. The participants had nothing to disclose except Dr. Gronseth.Dr. Gronseth serves as an editorial advisory board member of Neurology Now; serves on a speakers bureau for Boehringer Ingelheim; and receives honoraria from Boehringer Ingelheim and the American Academy of Neurology.

Familial essential tremor and update H1N1 and risk of GBS. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matt Barrett interviews Dr. Giuseppe Nicoletti about his paper on familial essential tremor. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about fibrocartilaginous embolism myelopathy. In the next part of the podcast Dr. Ted Burns interviews Dr. Jim Sejvar for our Lesson of the Week about H1N1 vaccination and risk of GBS an update. The participants had nothing to disclose except Dr. Burns.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).